James Jenkins
About James Jenkins
James Jenkins is an independent director of ScanTech AI Systems Inc. (STAI) and co-chairs the Audit Committee; he also serves on the Compensation Committee . He is currently the Chief Executive Officer, Chairman, and President of Lakeland Industries, Inc.; previously he was General Counsel and Vice President of Corporate Development at Transcat, Inc. until June 1, 2024, and a longtime partner at Harter Secrest & Emery LLP . He holds a BA from the Virginia Military Institute and a J.D. from West Virginia University College of Law . As of the proxy record date, Jenkins was age 61 and a Class I director; he was not standing for re-election at the November 21, 2025 annual meeting and would serve until the expiration of his term at that meeting .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Transcat, Inc. (Nasdaq: TRNS) | General Counsel; VP Corporate Development; Chief Risk Officer; advisor to management and board on governance/securities; led M&A strategy | Sep 2020 – Jun 1, 2024 | Senior legal/governance leadership; risk oversight; M&A execution |
| Harter Secrest & Emery LLP | Partner; Chair, Securities Practice Group; Management Committee member; Partner in Charge (NYC) | Associate 1989; Partner 1997; Chair 2001–2020; Mgmt Committee 2007–2013; NYC lead 2018–Sep 2020 | Corporate governance, capital markets, M&A; Chambers-rated attorney |
| Lakeland Industries, Inc. | Director (prior term) | 2012–2015 | Member of board previously |
| Mars Acquisition Corp. | Committee member | Prior to business combination | Audit and Corporate Governance Committees member |
External Roles
| Organization | Role | Public/Private | Tenure | Committee Roles |
|---|---|---|---|---|
| Lakeland Industries, Inc. | CEO, Chairman & President | Public | Ongoing (current) | Board leadership (executive chair) |
Interlocks/overlaps: Jenkins is a sitting CEO/Chair of Lakeland while serving as an independent director at STAI; no related-party transactions involving Jenkins were disclosed by STAI in the last two fiscal years .
Board Governance
- Independence and status:
- Board determined Jenkins is independent under Nasdaq rules; only the CEO is non-independent .
- Board designated Jenkins an “audit committee financial expert” and financially sophisticated under Nasdaq rules .
- Committee assignments (as of Oct 14, 2025):
- Audit Committee: Jenkins (Co-Chair), Buswell (Co-Chair), Bottoms (Member) .
- Compensation Committee: Jenkins (Member); Bottoms (Chair); Buswell (Member) .
- Nominating & Corporate Governance Committee: McGarrity (Chair); Buswell (Member); Jenkins not a member .
- Committee formation and 2024 activity:
- Audit, Compensation, and Nominating Committees were formed in January 2025; they held no meetings during 2024 (formation timing) .
- Risk oversight:
- Audit Committee responsibilities include oversight of financial reporting, internal controls, and auditor independence; confidential reporting procedures are established .
- The board describes an active role in risk oversight at the full board and committee levels, including cybersecurity and data privacy under Audit; compensation risk under Compensation; independence/conflicts under Nominating & Governance .
Fixed Compensation
| Year | Role | Cash Fees ($) | Equity Awards ($) | Other ($) | Total ($) |
|---|---|---|---|---|---|
| 2024 | Non-employee Director | 50,000 | 200,000 | — | 250,000 |
- Policy guardrails and plan design:
- Non-Employee Director award cap: max total annual director compensation of $750,000 (first year) and $500,000 thereafter (cash plus equity, grant date fair value) .
Note: STAI’s definitive proxy states non-employee directors were appointed in January 2025 upon the business combination; therefore, 2024 director compensation disclosures in the preliminary proxy reflect the transition context and historical practice, whereas the definitive proxy does not list 2024 amounts for the newly appointed directors .
Performance Compensation
| Item | Detail |
|---|---|
| Performance metrics tied to director pay | Not specified for 2024 director equity awards; disclosed as dollar-value equity without enumerated performance criteria . |
| Plan features | Equity plan permits performance awards; also includes single-trigger change-in-control acceleration for options, RSUs, and performance awards . |
Other Directorships & Interlocks
| Company | Sector | Role | Potential Interlock/Conflict Notes |
|---|---|---|---|
| Lakeland Industries, Inc. | PPE/Apparel | CEO, Chairman & President (current) | No related-party transactions with STAI disclosed; board affirmed independence . |
| Mars Acquisition Corp. | SPAC | Former committee member (Audit; Corporate Governance) | Historical SPAC role; no ongoing interlock . |
Expertise & Qualifications
- Designated Audit Committee Financial Expert (SEC definition) based on education and financial/accounting experience .
- Deep governance, securities law, capital markets, and M&A expertise from decades as a law firm partner and Transcat corporate officer directing acquisition strategy and advising on governance and securities law .
- Executive leadership credentials as CEO/Chair of a public company (Lakeland) .
Equity Ownership
| As of Record Date (Oct 14, 2025) | Shares Beneficially Owned | % of Class | Composition/Notes |
|---|---|---|---|
| James Jenkins | 151,750 | <1% | 51,750 shares held directly; 100,000 shares issuable pursuant to RSUs within 60 days of the record date . |
- Pledging/hedging: No pledging disclosed; no related-party transactions involving Jenkins were disclosed in the last two fiscal years .
- Ownership guidelines: Not disclosed in the proxy materials reviewed .
Governance Assessment
- Strengths:
- Independence and financial sophistication: Board affirmed independence; Jenkins designated as audit committee financial expert—supports robust audit oversight .
- Relevant governance/M&A/legal expertise: Senior roles at Transcat and extensive securities/M&A background should aid oversight of capital markets, deals, and compliance .
- Risks/Red Flags:
- Financial reporting restatement and control weakness: On Nov 3, 2025, STAI filed an Item 4.02 8‑K stating Q1 and Q2 2025 financials should no longer be relied upon due to mis-timed recognition of compensation related to non-redemption share awards; management identified a material weakness in ICFR and is pursuing remediation. As Audit Co‑Chair, Jenkins will be central to remediation and auditor oversight—a key near‑term governance test .
- Auditor turnover: On Oct 6, 2025, the Audit Committee appointed Berkowitz Pollack Brant as the new independent auditor—audit continuity requires heightened audit committee diligence during restatement and remediation .
- Equity plan features: Single‑trigger change‑in‑control acceleration for director/participant equity awards and an evergreen provision adding up to 3% of outstanding shares annually may be shareholder‑unfriendly if not tightly governed; non‑employee director compensation caps are relatively high for a small/emerging issuer .
- Time commitments: Concurrent service as Lakeland’s CEO/Chair/President alongside STAI Audit Co‑Chair and Compensation member warrants monitoring for bandwidth and potential overboarding perceptions, though no conflicts/related‑party transactions are disclosed .
Outlook for board effectiveness: Jenkins’ audit expertise and public‑company leadership are positives, but investor confidence will hinge on successful, timely completion of restatements, ICFR remediation, and stable auditor oversight under the Audit Committee’s co‑chair structure .
Fixed Compensation (Detail)
| Component | Amount | Notes |
|---|---|---|
| Annual cash fees (2024) | $50,000 | As disclosed in preliminary proxy for 2024 non‑employee directors . |
| Annual equity (2024) | $200,000 | Form not specified, likely RSUs; valuation per ASC 718 fair value . |
| Meeting/committee fees | Not specified | Not detailed in reviewed filings . |
Performance Compensation (Metrics Table)
| Metric Category | Defined Targets | Weighting | Payout Curve | Notes |
|---|---|---|---|---|
| Financial (e.g., revenue, EBITDA, TSR) | Not disclosed | — | — | Proxy lists equity awards by dollar value; no director performance metrics enumerated . |
| ESG/Strategic | Not disclosed | — | — | Plan permits performance awards but metrics for director awards not specified . |
Related-Party/Conflicts Check
- Company disclosure states no related-party transactions meeting Item 404 thresholds during the last two fiscal years; no Jenkins-specific related-party items are listed .
- Family relationships: None among directors and executive officers .
Attendance and Engagement
- Committee formation in Jan 2025; no committee meetings in 2024 due to timing; specific 2025 attendance rates are not disclosed in the reviewed materials .
Director Term and Transition
- Class I director; Jenkins will not stand for re-election at the Nov 21, 2025 annual meeting and continues to serve until term expiration at that meeting .